Pennant Group [PNTG] vs Tenet Healthcare [THC] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Pennant Group, Inc. wins in 6 metrics, Tenet Healthcare Corporation wins in 14 metrics, with 0 ties. Tenet Healthcare Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pennant Group, Inc. | Tenet Healthcare Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.94 | 12.17 | Tenet Healthcare Corporation |
| Price-to-Book Ratio | 3.08 | 3.88 | Pennant Group, Inc. |
| Debt-to-Equity Ratio | 122.87 | 160.79 | Pennant Group, Inc. |
| PEG Ratio | 0.74 | 10.76 | Pennant Group, Inc. |
| EV/EBITDA | 24.80 | 7.05 | Tenet Healthcare Corporation |
| Profit Margin (TTM) | 3.12% | 6.60% | Tenet Healthcare Corporation |
| Operating Margin (TTM) | 6.25% | 17.46% | Tenet Healthcare Corporation |
| EBITDA Margin (TTM) | 6.25% | 17.46% | Tenet Healthcare Corporation |
| Return on Equity | 9.84% | 27.02% | Tenet Healthcare Corporation |
| Return on Assets (TTM) | 3.90% | 8.04% | Tenet Healthcare Corporation |
| Free Cash Flow (TTM) | $36.26M | $2.53B | Tenet Healthcare Corporation |
| 1-Year Return | 19.30% | 3.88% | Pennant Group, Inc. |
| Price-to-Sales Ratio (TTM) | 1.07 | 0.77 | Tenet Healthcare Corporation |
| Enterprise Value | $1.49B | $32.68B | Tenet Healthcare Corporation |
| EV/Revenue Ratio | 1.57 | 1.53 | Tenet Healthcare Corporation |
| Gross Profit Margin (TTM) | 13.57% | 81.73% | Tenet Healthcare Corporation |
| Revenue per Share (TTM) | $27 | $236 | Tenet Healthcare Corporation |
| Earnings per Share (Diluted) | $0.84 | $15.48 | Tenet Healthcare Corporation |
| Beta (Stock Volatility) | 1.30 | 1.50 | Pennant Group, Inc. |
| Short % of Float | 2.42% | 3.55% | Pennant Group, Inc. |
Pennant Group, Inc. vs Tenet Healthcare Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pennant Group, Inc. | -0.76% | -10.74% | -2.41% | -8.09% | 4.37% | 9.05% |
| Tenet Healthcare Corporation | 0.76% | -8.96% | -11.07% | -32.13% | -22.00% | -17.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pennant Group, Inc. | 19.30% | 176.21% | 1.75% | 114.06% | 114.06% | 114.06% |
| Tenet Healthcare Corporation | 3.88% | 135.08% | 158.85% | 506.43% | 601.28% | 444.47% |
Performance & Financial Health Analysis: Pennant Group, Inc. vs Tenet Healthcare Corporation
| Metric | PNTG | THC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.05B | $16.50B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 152,152 | 1,231,387 |
| 90 Day Avg. Volume | 226,704 | 1,117,252 |
| Last Close | $30.12 | $164.84 |
| 52 Week Range | $21.73 - $37.54 | $146.60 - $247.21 |
| % from 52W High | -19.77% | -33.32% |
| All-Time High | $69.56 (Jan 04, 2021) | $247.21 (Mar 05, 2026) |
| % from All-Time High | -56.70% | -33.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.53% | 0.09% |
| Quarterly Earnings Growth | 0.50% | 0.17% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.07% |
| Operating Margin (TTM) | 0.06% | 0.17% |
| Return on Equity (TTM) | 0.10% | 0.27% |
| Debt to Equity (MRQ) | 122.87 | 160.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $9.54 | $48.53 |
| Cash per Share (MRQ) | $0.49 | $33.15 |
| Operating Cash Flow (TTM) | $48.29M | $3.54B |
| Levered Free Cash Flow (TTM) | $7.21M | $1.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Pennant Group, Inc. vs Tenet Healthcare Corporation
| Metric | PNTG (Apr 24, 2026) | THC (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.94 | 12.17 |
| Forward P/E | 18.71 | 10.76 |
| PEG Ratio | 0.74 | 10.76 |
| Price to Sales (TTM) | 1.07 | 0.77 |
| Price to Book (MRQ) | 3.08 | 3.88 |
| Market Capitalization | ||
| Market Capitalization | $1.05B | $16.50B |
| Enterprise Value | $1.49B | $32.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.57 | 1.53 |
| Enterprise to EBITDA | 24.80 | 7.05 |
| Risk & Other Metrics | ||
| Beta | 1.30 | 1.50 |
| Book Value per Share (MRQ) | $9.54 | $48.53 |
Financial Statements Comparison: Pennant Group, Inc. vs Tenet Healthcare Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PNTG (2025) | THC (2025) |
|---|---|---|
| Revenue/Sales | 947.71M | 21.31B |
| Cost of Goods Sold | 817.20M | 3.78B |
| COGS % of Revenue | 86.2% | 17.7% |
| Gross Profit | 130.50M | 17.53B |
| Gross Margin | 13.8% | 82.3% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 50.89M | 3.44B |
| Operating Margin | 5.4% | 16.1% |
| EBITDA | 59.85M | 4.68B |
| EBITDA Margin | 6.3% | 22.0% |
| Pre-Tax Income | 45.63M | 2.80B |
| Pre-Tax Income % of Revenue | 4.8% | 13.1% |
| Income Tax | 11.87M | 433.00M |
| Income Tax % of Revenue | 1.3% | 2.0% |
| Net Income (Profit) | 33.76M | 1.41B |
| Profit Margin | 3.6% | 6.6% |
Balance Sheet & Liquidity Metrics
| Metric | PNTG (2025) | THC (2025) |
|---|---|---|
| Cash & Equivalents | 17.02M | 2.88B |
| Total Current Assets | 167.41M | 7.85B |
| Total Current Assets % of Revenue | 17.7% | 36.8% |
| Total Current Liabilities | 147.26M | 4.46B |
| Total Current Liabilities % of Revenue | 15.5% | 20.9% |
| Long-Term Debt | 423.15M | 13.09B |
| Long-Term Debt % of Revenue | 44.6% | 61.4% |
| Total Shareholders Equity | 374.25M | 8.97B |
| Retained Earnings | 86.80M | 4.42B |
| Retained Earnings % of Revenue | 9.2% | 20.7% |
| Property, Plant & Equipment | 313.64M | 6.71B |
Cash Flow Statement Comparison
| Metric | PNTG (2025) | THC (2025) |
|---|---|---|
| Operating Cash Flow | 33.89M | 3.51B |
| Operating Cash Flow % of Revenue | 3.6% | 16.5% |
| Capital Expenditures | -12.04M | -972.00M |
| Free Cash Flow | 36.26M | 2.53B |
| FCF Margin | 3.8% | 11.9% |
| Debt Repayment | -298.00M | -2.37B |
| Common Stock Repurchase | N/A | -1.39B |
Short Interest & Institutional Ownership Analysis
| Metric | PNTG | THC |
|---|---|---|
| Shares Short | 797,456 | 2.28M |
| Short Ratio | 3.00 | 2.20 |
| Short % of Float | 2.42% | 3.55% |
| Shares Outstanding | 34.63M | 86.95M |
| Float Shares | 33.00M | 85.97M |
| % Held by Insiders | 5.00% | 1.08% |
| % Held by Institutions | 97.01% | 98.33% |
| % Held by Public | -2.01% | 0.59% |
Dividend Analysis & Yield Comparison: Pennant Group, Inc. vs Tenet Healthcare Corporation
| Metric | PNTG | THC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |